InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,615.35
(
0.55%
)
US TECH 100
19,804.00
(
0.64%
)
Dow Jones
40,000.90
(
0.62%
)
Brent Oil
84.57
(
0.00%
)
Bitcoin
60,028.07
(
1.34%
)
Post# of 252592
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Mufaso

Send PM Follow Ignore
Followers 32
Posts 484
Boards Moderated 0
Alias Born 01/08/2008

Mufaso

Member Level

Re: DewDiligence post# 250017

Tuesday, 12/12/2023 3:22:45 PM

Tuesday, December 12, 2023 3:22:45 PM

Post# of 252592
Will do. I will also add Shionogi's S-309309 which has is an MGAT2 inhibitor. It completed ph1 (not much detail available on results there that I can find). There is some detail Shionogi's investor section saying it had promising safety but no info on % of weight loss etc. It is in ph2

https://clinicaltrials.gov/study/NCT05925114?term=%20S-309309&rank=2

Been doing some research to see if I missed anything else of significance and will update when I have run a few more things down.

"People are best convinced by reasons they discover themselves"

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up